logo

   

Need a supporting hand in manuscript formatting? Write to our team.
Assistance in presubmission | editorialoffice@clinmedjournals.org

     
 
Obstetrics and Gynaecology Cases - Reviews
ISSN: 2377-9004
REVIEW ARTICLE | VOLUME 5, ISSUE 3 | OPEN ACCESS DOI: 10.23937/2377-9004/1410124

Early Pregnancy Loss: A Management Guide

Paul R Brezina

Assistant Professor, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, USA

*Corresponding author: Paul R Brezina, MD, MBA, Assistant Professor, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, B-1100 Medical Center North, Nashville, Tennessee 37232, USA, Tel: 901-747-2227, Fax: 901-747-4449, E-mail: paul.r.brezina@vanderbilt.edu, brezinamd@gmail.com

Accepted: May 28, 2018 | Published: May 30, 2018

Citation: Brezina PR (2018) Early Pregnancy Loss: A Management Guide. Obstet Gynecol Cases Rev 5:124. doi.org/10.23937/2377-9004/1410124

Copyright: © 2018 Brezina PR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract


One of the most difficult aspects of reproductive medicine is the management of recurrent pregnancy loss. Recurrent pregnancy loss is one of the most emotionally devastating challenges facing couples who want to grow their family. For many couples, risk factors that increase the chances of experiencing a loss can be identified and treated. For other couples, however, a definitive cause is never identified. The aim of this article is to outline the causes for recurrent pregnancy loss and available therapies that optimize pregnancy outcomes.

Keywords


Recurrent pregnancy loss, RPL, Miscarriage, Spontaneous abortion, Embryo, Aneuploid, Antiphospholipid, Lupus anticoagulant, Heparin

Introduction


While spontaneous abortion occurs in approximately 15% of clinically diagnosed pregnancies of reproductive aged women, recurrent pregnancy loss occurs in about 1-2% of this same population [1]. Great strides have been made in characterizing the incidence and diversity of this heterogeneous disorder and a cause of increased propensity to experience pregnancy loss can be established in over half of couples after a thorough evaluation [2,3]. A complete evaluation will include investigations into genetic, endocrinologic, anatomic, immunologic and iatrogenic causes. These causes are then treated, resulting in an increased chance of achieving pregnancy in many patients. However, while all such therapies are aimed at decreasing the chances of recurrent pregnancy loss, no intervention is capable of completely eliminating the chance of miscarriage in the future. The traditional definition of recurrent pregnancy loss (RPL) included those couples with three or more spontaneous, consecutive pregnancy losses. Ectopic and molar pregnancies are not included. More recently, The American Society for Reproductive Medicine (ASRM) has defined RPL as "a distinct disorder defined by 2 or more failed clinical pregnancies [4]". The authors of this paper recommend a RPL evaluation after 2 or more pregnancy losses.

Anatomic Causes of Rpl


Anatomic causes of RPL are typically diagnosed using hysterosalpingography (HSG) or sonohysterography, commonly with three-dimensional ultrasonography. Hysteroscopy, laparoscopy, or magnetic resonance imaging (MRI) can supplement these tests as needed. The treatment of congenital and acquired uterine anomalies often involves corrective surgery.

Congenital malformations

Congenital malformations of the reproductive tract are present at the time of birth. The most common congenital abnormality associated with pregnancy loss is the septate uterus. The spontaneous abortion rate is high, averaging about 65% of pregnancies in some studies [4]. A septum is primarily composed of fibromuscular tissue that is poorly vascularized, making normal growth of the placenta difficult. Other congenital abnormalities, such as uterine didelphys, bicornuate and unicornuate uterus are more frequently associated with later trimester losses or preterm delivery.

Intrauterine adhesions

Intrauterine trauma resulting from a D+C or uterine infection is associated with a risk for the development of scar tissue (adhesions) within the uterus. This scar tissue may completely replace normal uterine tissue or make implantation and growth of an embryo more difficulty. Thankfully, in many cases, these adhesions may be treated with surgical resection.

Intrauterine masses

Intrauterine cavity abnormalities, such as fibroids and polyps, can contribute to pregnancy loss. Depending on the size and location, these masses may compromise the ability of an embryo to implant and growth. Thankfully, in most cases, these masses may be treated with surgical resection [5].

Cervical weakness

Cervical weakness is defined as the propensity for the cervix to dilate prematurely without cause. Cervical incompetence commonly causes pregnancy loss in the second, rather than first, trimester. It may be associated with congenital uterine abnormalities such as septate or bicornuate uterus. It is postulated that most cases occur as a result of surgical trauma to the cervix from conization, loop electrosurgical excision procedures, overdilation of the cervix during pregnancy termination, or obstetric lacerations [6].

Endocrinologic Causes of Rpl


Endocrine factors may contribute to 8-12 percent of recurrent pregnancy loss. Therefore, an endocrinologic evaluation is a critical component of the RPL workup.

Luteal phase deficiency

Maintenance of early pregnancy depends on the production of progesterone by the corpus luteum. Between 7 and 9 weeks of gestation the developing placenta takes over the progesterone production. Luteal phase deficiency (LPD) is defined as an inability of the corpus luteum to secrete progesterone in high enough amounts or for too short a duration. Traditionally, a diagnosis of LPD was diagnosed based on blood progesterone levels [7]. However, progesterone levels are subject to large fluctuations because of pulsatile release of the LH hormone, making blood progesterone levels generally unreliable [8]. While conflicting data exist, a recent Cochrane review evaluating 15 trials concluded that there was a benefit to the routine administration of progesterone to all women with a history of RPL [9,10].

Untreated hypothyroidism

Untreated hypothyroidism may increase the risk of miscarriage. A study of over 700 patients with recurrent pregnancy loss identified 7.6% with hypothyroidism [11]. Hypothyroidism is easily diagnosed with a sensitive TSH test and patients should be treated to become euthyroid (defined for the purposes of RPL as between 1.0 and 2.5 uIU/mL) before and during pregnancy [12].

Abnormal glucose metabolism

Patients with poorly controlled diabetes are known to have an increased risk of spontaneous miscarriage, which is reduced to normal spontaneous loss rates when women are euglycemic preconceptually [13]. Testing for fasting insulin and glucose is simple and treatment with insulin-sensitizing agents can reduce the risk of recurrent miscarriage [14]. Because there is strong evidence that obesity and/or insulin resistance are associated with an increased risk of miscarriage, weight reduction in obese women is a first step in the treatment.

Hyperprolactinemia

Normal circulating levels of prolactin may play an important role in maintaining early pregnancy Data from animal studies suggest that elevated prolactin levels may adversely affect corpus luteal function; however, this concept has not been proven in humans [15]. A recent study of 64 hyperprolactinemic women showed that bromocriptine therapy was associated with a higher rate of successful pregnancy and that prolactin levels were significantly higher in women who miscarried [16,17].

Autoimmune/Thrombotic Factors as the Cause of Rpl


Immunologic disorders

Autoimmune factors: Maternal response to self

In some instances, there is a failure in normal control mechanisms that prevent an immune reaction against self, resulting in an autoimmune response [18]. Autoantibodies to phospholipids, thyroid antigens, nuclear antigens and others have been investigated as possible causes for pregnancy loss [11]. Antiphospholipid antibodies include the lupus anticoagulant, Anti-beta 2 glycoproteinIantibodies, and anticardiolipin antibodies. There is still controversy concerning testing for other phospholipids, but an increasing number of studies suggest that antibodies to phosphatidyl serine are also associated with pregnancy loss [19]. Women with systemic lupus erythematosus and aPL have increased risks for miscarriage compared to those with lupus and negative aPL [1].

Microbiologic

Certain infectious agents have been identified more frequently in cultures from women who have had spontaneous pregnancy losses [20]. These include Ureaplasma urealyticum, Mycoplasma hominis,, and Chlamydia. Other less frequent pathogens include toxoplasma gondi, rubella, HSV, measles, CMV, coxsackievirus and listeria monocytogenes. It is important to be aware that none of these pathogens have been causally linked to RPL. Because of the association with sporadic pregnancy losses and the ease of diagnosis, some clinicians will test women with RPL and treat for the appropriate pathogen in both parents.

Thrombotic disorders

Thrombophilias, including factor V Leiden, Antitrombin activity, Protein C+S activation, and MTHFR mutations are now not thought to be associated with RPL. However, these abnormalities are thought to be responsible for more than half of maternal venous thromboembolisms in pregnancy, however ACOG recommends that only patients with a personal or family history of thromboembolic events should be tested [21].

Genetic Factors as the Cause of Rpl


There are a variety of genetic factors that may result in failure of a pregnancy to develop. The overall frequency of chromosome abnormalities in spontaneous abortions exceeds 50% [22-26]. These abnormalities include aneuploidy (the gain or loss of a chromosome), chromosomal imbalances as a result of parentally harbored translocations or inversions, deletions or duplications of genetic information within chromosomes, and single-gene mutations. Broadly, genetic factors may be divided into embryonic errors derived from known parental chromosomal abnormalities and embryonic errors that arise de novo in apparently chromosomally normal parents.

Parental chromosomal disorders

Parental chromosome anomalies occur in 3-5% of couples with RPL as opposed to 0.7% in the general population. These include translocations, inversions, and the relatively rare ring chromosomes. Balanced translocations are the most common chromosomal abnormalities contributing to recurrent pregnancy loss [22]. Chromosomal abnormalities in one of the parents can be found in up to 3-5% of couples who experience multiple spontaneous abortions. If no fetal POC are available and the couple has a history of at least 2 consecutive or 3 nonconsecutive fetal losses, we recommend obtaining parental karyotypes.

Genetic causes of RPL may be subdivided into embryo abnormalities that are the result of known parental abnormalities (such as parental balanced translocations or inversions) and embryo aneuploidy in parents believed to be chromosomally normal. Preimplantation genetic testing is a technology that is designed to minimize the effects of these and other embryonic genetic abnormalities. Preimplantation genetic testing is accomplished by performing an in vitro fertilization (IVF) cycle, removing a cell(s) from the resultant embryos or oocytes, evaluating this cell for genetic abnormalities, and using the results to determine which embryos are ideal for uterine transfer. Recent data evaluating pregnancy rates in RPL patients using 23 chromosome microarrays are encouraging [27,28].

Lifestyle Issues and Environmental Toxins


Couples experiencing recurrent pregnancy losses are often concerned those toxins within the environment may have contributed to their reproductive difficulty. It is important that health care providers, counseling patients about exposures to substances in the environment, have current and accurate information in order to respond to these concerns.

Cigarette smoking

Cigarette smoking reduces fertility and increases the rate of spontaneous abortion. The data evaluating smoking and miscarriage are extensive and involve approximately 100,000 subjects. The studies suggest a clinically significant detrimental effect of cigarette smoking that is dose dependent, with a relative risk for miscarriage among moderate smokers (10-20 cigarettes a day) being 1.1 to 1.3 [29]. Patients should be aggressively counseled to stop cigarette smoking prior to attempting pregnancy.

Alcohol consumption

Alcohol consumption associated with a risk of spontaneous abortion [30]. The minimum threshold dose for significantly increasing the risk of first trimester miscarriage appears to be 2 or more alcoholic drinks per week [31,32]. When personal habits, cigarette smoking and alcohol are utilized in the same individual, the risk of pregnancy loss may increase 4-fold. Couples should be counseled concerning these habits and strongly encouraged to discontinue these prior to attempting subsequent conception [33].

Obesity

Obesity, defined as a body mass index over 30, has been associated with an increased risk of miscarriage. Obesity (BMI > 30 kg/m2) has been shown to be an independent risk factor for first trimester miscarriage [34]. The association is strongest in women with BMI > 40. The etiology of this phenomenon is unclear. However, many studies have linked obesity to a generalized increase in systemic inflammatory responses [35].

Caffeine intake

Several studies have shown that caffeine in excess of 300 mg/day (3 cups of coffee per day) is associated with a modest increase in spontaneous abortion, but it is not clear if this relationship is causal [36].

Outcome


Thankfully, the prognosis for women with RPL to eventually deliver with medical therapy is quite good. Women who suffer RPL have already begun to prepare for their baby, both emotionally and physically, as compared to couples with infertility who have never conceived. When a miscarriage occurs, a couple may have great difficulty informing friends or family about the loss. Feelings of hopelessness may continue long after the loss. Patients may continue to grieve and have episodes of depression on the expected due date or the date of the pregnancy loss. Participation in support groups or referral for grief counseling may be beneficial in many cases (SHARE, Pregnancy and Infant Loss Support, Inc., www.nationalshareoffice.com).

Contributors


PRB primarily searched the literature. PRB wrote the first draft of the manuscript; PRB edited the manuscript and advised on the content of the manuscript, assisted in the literature search, and contributed to the writing of the manuscript. PRB is guarantor.

Funding


None.

Competing Interests


All authors have completed the Unified Competing Interest form and declare: No support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.

References


  1. Brezina PR, Kutteh WH (2014) Classic and cutting-edge strategies for the management of early pregnancy loss. Obstet Gynecol Clin North Am 41: 1-18.

  2. Stephenson MD (1996) Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 66: 24-29.

  3. Jaslow CR, Carney JL, Kutteh WH (2010) Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 93: 1234-1243.

  4. The Practice Committee of the American Society for Reproductive Medicine (2012) Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertil Steril 98: 1103-1111.

  5. Surrey ES, Lietz AK, Schoolcraft WB (2001) Impact of intramural leiomyomate in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril 75: 405-410.

  6. American College of Obstetrics and Gynecologist (2003) ACOG practice bulletin. Cervical insufficiency. Obstet Gynecol 102: 1091-1099.

  7. Cumming DC, Honore LH, Scott JZ, Williams KP (1985) The late luteal phase in infertile women: comparison of simultaneous endometrial biopsy and progesterone levels. Fertil Steril 43: 715-719.

  8. Shepard MK, Senturia YD (1977) Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function. Fertil Steril 28: 541-548.

  9. Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers TC (1989) A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 96: 265-274.

  10. Haas DM, Ramsey PS (2008) Progestogen for preventing miscarriage. Cochrane Database Syst Rev.

  11. Ghazeeri GS, Kutteh WH (2001) Immunological testing and treatment in reproduction: Frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod 16: 2130-2135.

  12. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, et al. (2012) Management of thyroid dysfunction during pregnancy and postpartum: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 97: 2543-2565.

  13. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, et al. (1988) Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319: 1617-1623.

  14. Sills ES, Perloe M, Palermo GD (2000) Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: A review of therapeutic rationale and reproductive outcomes. Eur J Obstet Gynecol Reprod Biol 91: 135-141.

  15. Dlugi AM (1998) Hyperprolactinemic recurrent spontaneous pregnancy loss: a true clinical entity or a spurious finding? Fertil Steril 70: 253-255.

  16. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, et al. (1998) Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 70: 246-252.

  17. Hofmann GE, Khoury J, Thie J (2000) Recurrent pregnancy loss and diminished ovarian reserve. Fertil Steril 74: 1192-1195.

  18. Kutteh WH (1996) Immunology of multiple endocrinopathies associated with premature ovarian failure. The Endocrinologist 6: 462-466.

  19. Franklin RD, Kutteh WH (2002) Antiphospholipid antibodies (APA) and recurrent pregnancy loss: Treating a unique APA positive population. Hum Reprod 17: 2981-2985.

  20. Penta M, Lukic A, Conte MP, Chiarini F, Fioriti D, et al. (2003) Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol 26: 329-337.

  21. Lockwood C, Wendel G, Committee on Practice Bulletins- Obstetrics (2011) Practice bulletin no. 124: Inherited thrombophilias in pregnancy. Obstet Gynecol 118: 730-740.

  22. Hirshfeld-Cytron J, Sugiura-Ogasawara M, Stephenson MD (2011) Management of recurrent pregnancy loss associated with a parental carrier of a reciprocal translocation: A systematic review. Semin Reprod Med 29: 470-481.

  23. Hassold T, Chen N, Funkhouser J, Jooss T, Manuel B, et al. (1980) A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet 44: 151-178.

  24. Werner M, Reh A, Grifo J, Perle MA (2012) Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. J Assist Reprod Genet 29: 817-820.

  25. Nayak S, Pavone ME, Milad M, Kazer R (2011) Aneuploidy rates in failed pregnancies following assisted reproductive technology. J Womens Health (Larchmt) 20: 1239-1243.

  26. Coulam CB, Goodman C, Dorfmann A (1997) Comparison of ultrasonographic findings in spontaneous abortions with normal and abnormal karyotypes. Hum Reprod 12: 823-826.

  27. Brezina PR, Brezina DS, Kearns WG (2012) Preimplantation genetic testing. BMJ 345: e5908.

  28. Wells D, Alfarawati S, Fragouli E (2008) Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod 14: 703-710.

  29. Gardella JR, Hill JA 3rd (2000) Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 18: 407-424.

  30. Harlap S, Shiono PH (1980) Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 2: 173-176.

  31. Kline J, Shroat P, Stein ZA, Susser M, Warburton D (1980) Drinking during pregnancy and spontaneous abortion. Lancet 2: 176-180.

  32. Andersen AM, Andersen PK, Olsen J, Grønbæk M, Strandberg-Larsen K (2012) Moderate alcohol intake during pregnancy and risk of fetal death. Int J Epidemiol 41: 405-413.

  33. Ness RB, Grisso JA, Hrischinger N, Markovic N, Shaw LM, et al. (1999) Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 340: 333-339.

  34. Smith ML, Schust DJ (2011) Endocrinology and recurrent early pregnancy loss. Semin Reprod Med 29: 482-490.

  35. Johnson AR, Justin Milner J, Makowski L (2012) The inflammation highway: Metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249: 218-238.

  36. Dlugosz L, Bracken MB (1992) Reproductive effects of caffeine: A review and theoretical analysis. Epidemiol Rev 4: 83-100.